Skip to main contentSkip to navigation
Sirius Investors

GNOM Stock: Global X Genomics & Biotechnology ETF Stock Price, Analysis & Insights

Get live gnom stock price $46.20, comprehensive Global X Genomics & Biotechnology ETF stock analysis, charts, news, and expert forecast. Real-time gnom stock data and investment insights.

46.20
0.07%Today
GNOMGlobal X Genomics & Biotechnology ETF • NASDAQ Global Market • Financial Services
Market Cap
54.27M
Volume
732
52W High
47.82
52W Low
27.20

Loading chart...

Company Overview

The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.

Company Information

CEO
Sector
Financial Services
Industry
Asset Management - Global
Employees
N/A

Contact Information

Website
Address
Country
US

Investment Analysis & Business Insights

Financial Services
Asset Management - Global

Investment Highlights

Strong presence in the Financial Services sector with established market position

Higher growth potential with elevated volatility (Beta: 1.80)

Business Model & Strategy

Global X Genomics & Biotechnology ETF operates in the Asset Management - Global industry, focusing on financial intermediation, banking services, and investment management. The company the company navigates Financial Services sector dynamics while pursuing growth opportunities. The Asset Management - Global model requires risk management, regulatory compliance, and customer trust to maintain competitiveness and drive shareholder value.

Market Position & Competitive Landscape

Global X Genomics & Biotechnology ETF competes in the Asset Management - Global within the broader Financial Services. With 54.3 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Financial Services is characterized by economic cycles, regulatory evolution, and digital transformation. As a publicly traded company on the NASDAQ Global Market, Global X Genomics & Biotechnology ETF provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Global X Genomics & Biotechnology ETF should consider industry-specific trends, competitive positioning, and Financial Services sector fundamentals.

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Global X Genomics & Biotechnology ETF shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Financial Services may affect company performance
  • Past performance does not guarantee future results for Global X Genomics & Biotechnology ETF
  • Investors should consider how Global X Genomics & Biotechnology ETF fits within their overall portfolio allocation

Market Cap

54.27M

Beta

1.80

Investment Analysis & Insights

Key Investment Highlights

  • Market Position: Financial Services leader with 54.27M market capitalization
  • Trading Volume: 732 shares traded today
  • Price Range: 52-week range of $27.20 - $47.82
  • Exchange: Listed on NASDAQ Global Market

Financial Metrics

P/E Ratio:N/A
EPS:$N/A
Beta:1.80
Avg Volume:12.64K

Market Analysis for Global X Genomics & Biotechnology ETF

Global X Genomics & Biotechnology ETF (GNOM) operates in the Asset Management - Global industry within the Financial Services sector. With a current market capitalization of 54.27M, the company represents a significant player in its market. The stock is currently trading at $46.20 with a negativedaily change of 0.07%.

The company's substantial employee base and presence on the NASDAQ Global Marketexchange position it as a Financial Services sector leader. Investors should consider the stock's P/E ratio of N/A, beta of 1.80, and 52-week price range from $27.20 to $47.82when evaluating investment opportunities.

Why Invest in Global X Genomics & Biotechnology ETF?

Strengths
  • • Established market presence in Financial Services
  • • Strong financial metrics and market position
  • • Listed on major exchange (NASDAQ Global Market)
  • • Experienced leadership under
Investment Considerations
  • • Monitor sector-specific market trends
  • • Track quarterly earnings performance
  • • Consider market volatility and beta
  • • Evaluate long-term growth potential

Related Financial Services Stocks

About Financial Services Sector

The Financial Services sector includes companies that provide banking, insurance, investment, and other financial services to consumers and businesses.